Poll: What do you consider the optimal approach for treating high-risk prostate cancer?

Study supports use of androgen receptor inhibitors in older men with nmCRPC

Adjuvant RT may improve post-prostatectomy outcomes vs early salvage RT in men with adverse pathology

Obesity Paradox in prostate cancer: potential explanations and next research steps